Search Within

Philip Wayne Kantoff

Formats
  1. Journal Article (118)
  2. Meeting Abstract (71)
  3. Review (4)
  4. Correspondence (2)
  5. Editorial (2)
  6. Research Letter (1)
Groups
  1. Department of Medicine (198)
  2. Genitourinary Oncology Service (198)
  3. Solid Tumor Oncology Division (198)
  4. Sloan Kettering Institute Postdocs (71)
  5. GSK Faculty (26)
  6. Human Oncology and Pathogenesis Program (23)

More Groups

People
  1. Konrad Stopsack (44)
  2. Goutam Chakraborty (29)
  3. Ying Mazzu (29)
  4. Subhiksha Nandakumar (27)
  5. Michael Morris (26)
  6. Yuki Yoshikawa (23)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (3)
  4. 2022 (14)
  5. 2021 (19)
  6. 2020 (34)

More Years

Publications
  1. Journal of Clinical Oncology (57)
  2. Clinical Cancer Research (17)
  3. Cancer Research (16)
  4. Cancer (9)
  5. Cancer Epidemiology Biomarkers and Prevention (8)
  6. European Urology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (62)
  2. American Association for Cancer Research (46)
  3. Nature Publishing Group (16)
  4. Oxford University Press (11)
  5. Wiley Blackwell (11)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (198)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A clinical evaluation of enzalutamide in metastatic castration-sensitive prostate cancer: Guiding principles for treatment selection and perspectives on research
    Review

    Laccetti, A. L.; Morris, M. J.; Kantoff, P. W.
    OncoTargets and Therapy (2020)

    Fulltext@MSK | Save
  • Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC) - Final PROCEED analysis
    Meeting Abstract

    Sartor, O.; Armstrong, A. J.; Ahaghotu, C.; McLeod, D. G.; Cooperberg, M. R.; Penson, D. F.; Kantoff, P. W.; Vogelzang, N. J.; Hussain, A.; Pieczonka, C. M.; more...
    Cancer Epidemiology Biomarkers and Prevention (2020)

    Fulltext@MSK | Save
  • Single-cell multiplex immunofluorescence of formalin-fixed, paraffin-embedded prostate cancer tissue identifies PI3K pathway activation in two prospective cohort studies
    Meeting Abstract

    Stopsack, K. H.; Huang, Y.; Tyekucheva, S.; Gerke, T. A.; Bango, C.; Elfandy, H.; Gao, X.; Cai, Z.; Roberts, T. M.; Kantoff, P. W.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • Effects of electroacupuncture and auricular acupuncture for chronic pain in cancer survivors: The PEACE randomized controlled trial
    Meeting Abstract

    Mao, J. J.; Liou, K.; Panageas, K.; Baser, R. E.; Romero, S. A. D.; Li, Q. S.; Xiao, H.; Bao, T.; Kantoff, P. W.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Diversity of enrollment in prostate cancer clinical trials: Current status and future directions
    Meeting Abstract

    Rencsok, E.; Bazzi, L.; McKay, R.; Huang, F.; Friedant, A.; Vinson, J.; Zarif, J.; Simmons, S.; Villanti, P.; Kantoff, P.; more...
    Cancer Epidemiology Biomarkers and Prevention (2020)

    Fulltext@MSK | Save
  • Pan-cancer analysis of CDK12 alterations identifies a subset of prostate cancers with distinct genomic and clinical characteristics
    Journal Article

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H. I.; Kantoff, P. W.; Gopalan, A.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • Patterns of self-reported care in a cohort of prostate cancer survivors: Implications for risk-stratified care
    Journal Article

    Nekhlyudov, L.; Blackmon, J. E.; Kantoff, P.; Recklitis, C. J.
    Journal of Geriatric Oncology (2020)

    Fulltext@MSK | Save
  • Racial differences in genomic profiling of prostate cancer - To the editor
    Research Letter

    Mahal, B. A.; Alshalalfa, M.; Kensler, K. H.; Chowdhury-Paulino, I.; Kantoff, P.; Mucci, L. A.; Schaeffer, E. M.; Spratt, D.; Yamoah, K.; Nguyen, P. L.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Event-free survival, a prostate-specific antigen-based composite end point, is not a surrogate for overall survival in men with localized prostate cancer treated with radiation
    Journal Article

    Xie, W.; Regan, M. M.; Buyse, M.; Halabi, S.; Kantoff, P. W.; Sartor, O.; Soule, H.; Berry, D.; Clarke, N.; Collette, L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: Outcomes from the PROCEED registry
    Journal Article

    Sartor, O.; Armstrong, A. J.; Ahaghotu, C.; McLeod, D. G.; Cooperberg, M. R.; Penson, D. F.; Kantoff, P. W.; Vogelzang, N. J.; Hussain, A.; Pieczonka, C. M.; more...
    Prostate Cancer and Prostatic Diseases (2020)

    Fulltext@MSK | Save